Cross Country Healthcare Q1 2024 Adj EPS $0.19 Beats $0.17 Estimate, Sales $379.174M Beat $374.089M Estimate
Cross Country Healthcare Q1 2024 Adj EPS $0.19 Beats $0.17 Estimate, Sales $379.174M Beat $374.089M Estimate
Cross Country Healthcare 2024年第一季度調整後的每股收益爲0.19美元，超過預期的0.17美元，銷售額爲3.79174億美元，超過3.74億美元的預期
Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.17 by 11.76 percent. This is a 77.38 percent decrease over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $379.174 million which beat the analyst consensus estimate of $374.089 million by 1.36 percent. This is a 39.11 percent decrease over sales of $622.707 million the same period last year.
Cross Country Healthcare（納斯達克股票代碼：CCRN）公佈的季度收益爲每股0.19美元，比分析師普遍預期的0.17美元高出11.76％。與去年同期的每股收益0.84美元相比，下降了77.38％。該公司公佈的季度銷售額爲3.79174億美元，比分析師普遍預期的3.74089億美元高出1.36％。這比去年同期的6.22707億美元銷售額下降了39.11％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。